silpharm limited
silpharm limited Company Information
Company Number
01679089
Website
http://numark-pharmacy.co.ukRegistered Address
11-12 hallmark trading centre, fourth way, wembley, middlesex, HA9 0LB
Industry
Letting and operating of own or leased real estate (other than Housing Association real estate and conference and exhibition services) n.e.c.
Telephone
08450941237
Next Accounts Due
84 days late
Group Structure
View All
Shareholders
harish dahyabhai patel 37%
dhimantkumar dahyabhai patel 36%
View Allsilpharm limited Estimated Valuation
The estimated valuation range for silpharm limited, derived from financial data as of April 2022 and the most recent industry multiples, is between £79.8k to £2.1m
silpharm limited Estimated Valuation
The estimated valuation range for silpharm limited, derived from financial data as of April 2022 and the most recent industry multiples, is between £79.8k to £2.1m
silpharm limited Estimated Valuation
The estimated valuation range for silpharm limited, derived from financial data as of April 2022 and the most recent industry multiples, is between £79.8k to £2.1m
Get a detailed valuation report, edit figures and unlock valuation multiples.
Silpharm Limited AI Business Plan
In just minutes, we combine Pomanda’s company and industry data with cutting edge Artificial Intelligence to build a comprehensive 27 section business plan. You then have 60 days to tailor the information, decide which sections to include or exclude, and add your own branding logos, images and color scheme to create your perfect plan.
Silpharm Limited Overview
Silpharm Limited is a live company located in wembley, HA9 0LB with a Companies House number of 01679089. It operates in the other letting and operating of own or leased real estate sector, SIC Code 68209. Founded in November 1982, it's largest shareholder is harish dahyabhai patel with a 37% stake. Silpharm Limited is a mature, small sized company, Pomanda has estimated its turnover at £1.1m with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Silpharm Limited Health Check
Pomanda's financial health check has awarded Silpharm Limited a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 5 areas for improvement. Company Health Check FAQs
4 Strong
1 Regular
5 Weak
Size
annual sales of £1.1m, make it larger than the average company (£673.1k)
- Silpharm Limited
£673.1k - Industry AVG
Growth
3 year (CAGR) sales growth of -17%, show it is growing at a slower rate (1%)
- Silpharm Limited
1% - Industry AVG
Production
with a gross margin of 28%, this company has a higher cost of product (71.7%)
- Silpharm Limited
71.7% - Industry AVG
Profitability
an operating margin of 1.6% make it less profitable than the average company (43.4%)
- Silpharm Limited
43.4% - Industry AVG
Employees
with 1 employees, this is below the industry average (4)
1 - Silpharm Limited
4 - Industry AVG
Pay Structure
on an average salary of £30k, the company has an equivalent pay structure (£30k)
- Silpharm Limited
£30k - Industry AVG
Efficiency
resulting in sales per employee of £1.1m, this is more efficient (£155.1k)
- Silpharm Limited
£155.1k - Industry AVG
Debtor Days
it gets paid by customers after 146 days, this is later than average (34 days)
- Silpharm Limited
34 days - Industry AVG
Creditor Days
its suppliers are paid after 68 days, this is slower than average (38 days)
- Silpharm Limited
38 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Silpharm Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Silpharm Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 23.7%, this is a lower level of debt than the average (66.9%)
23.7% - Silpharm Limited
66.9% - Industry AVG
silpharm limited Credit Report and Business Information
Silpharm Limited Competitor Analysis
Perform a competitor analysis for silpharm limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.
silpharm limited Ownership
SILPHARM LIMITED group structure
Silpharm Limited has no subsidiary companies.
Ultimate parent company
SILPHARM LIMITED
01679089
silpharm limited directors
Silpharm Limited currently has 2 directors. The longest serving directors include Mr Dhimantkumar Patel (Dec 1991) and Mr Harish Patel (Dec 1991).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Dhimantkumar Patel | United Kingdom | 67 years | Dec 1991 | - | Director |
| Mr Harish Patel | United Kingdom | 70 years | Dec 1991 | - | Director |
SILPHARM LIMITED financials
Silpharm Limited's latest turnover from April 2022 is estimated at £1.1 million and the company has net assets of £478 thousand. According to their latest financial statements, Silpharm Limited has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Apr 2022 | Apr 2021 | Apr 2020 | Apr 2019 | Apr 2018 | Apr 2017 | Apr 2016 | Apr 2015 | Apr 2014 | Apr 2013 | Apr 2012 | Apr 2011 | Apr 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | |||||||||||||
| Other Income Or Grants | |||||||||||||
| Cost Of Sales | |||||||||||||
| Gross Profit | |||||||||||||
| Admin Expenses | |||||||||||||
| Operating Profit | |||||||||||||
| Interest Payable | |||||||||||||
| Interest Receivable | |||||||||||||
| Pre-Tax Profit | |||||||||||||
| Tax | |||||||||||||
| Profit After Tax | |||||||||||||
| Dividends Paid | |||||||||||||
| Retained Profit | |||||||||||||
| Employee Costs | |||||||||||||
| Number Of Employees | 1 | 1 | 1 | ||||||||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Apr 2022 | Apr 2021 | Apr 2020 | Apr 2019 | Apr 2018 | Apr 2017 | Apr 2016 | Apr 2015 | Apr 2014 | Apr 2013 | Apr 2012 | Apr 2011 | Apr 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 185,791 | 189,083 | 189,496 | 181,242 | 181,242 | 181,242 | 181,242 | 181,617 | 181,992 | 182,367 | 182,742 | 183,117 | 183,492 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 185,791 | 189,083 | 189,496 | 181,242 | 181,242 | 181,242 | 181,242 | 181,617 | 181,992 | 182,367 | 182,742 | 183,117 | 183,492 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 440,683 | 424,544 | 415,707 | 450,197 | 443,294 | 447,765 | 422,280 | 193,433 | 193,991 | 269,491 | 210,424 | 229,709 | 301,458 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 0 | 0 | 0 | 0 | 0 | 0 | 70,911 | 345,969 | 357,665 | 82,739 | 641,048 | 648,637 | 364,456 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 440,683 | 424,544 | 415,707 | 450,197 | 443,294 | 447,765 | 493,191 | 539,402 | 551,656 | 352,230 | 851,472 | 878,346 | 665,914 |
| total assets | 626,474 | 613,627 | 605,203 | 631,439 | 624,536 | 629,007 | 674,433 | 721,019 | 733,648 | 534,597 | 1,034,214 | 1,061,463 | 849,406 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 148,517 | 149,517 | 143,410 | 178,570 | 182,470 | 175,570 | 230,955 | 228,612 | 249,910 | 61,220 | 272,432 | 380,781 | 160,953 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current liabilities | 148,517 | 149,517 | 143,410 | 178,570 | 182,470 | 175,570 | 230,955 | 228,612 | 249,910 | 61,220 | 272,432 | 380,781 | 160,953 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 292,432 | 212,432 | 212,432 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 292,432 | 212,432 | 212,432 |
| total liabilities | 148,517 | 149,517 | 143,410 | 178,570 | 182,470 | 175,570 | 230,955 | 228,612 | 249,910 | 61,220 | 564,864 | 593,213 | 373,385 |
| net assets | 477,957 | 464,110 | 461,793 | 452,869 | 442,066 | 453,437 | 443,478 | 492,407 | 483,738 | 473,377 | 469,350 | 468,250 | 476,021 |
| total shareholders funds | 477,957 | 464,110 | 461,793 | 452,869 | 442,066 | 453,437 | 443,478 | 492,407 | 483,738 | 473,377 | 469,350 | 468,250 | 476,021 |
| Apr 2022 | Apr 2021 | Apr 2020 | Apr 2019 | Apr 2018 | Apr 2017 | Apr 2016 | Apr 2015 | Apr 2014 | Apr 2013 | Apr 2012 | Apr 2011 | Apr 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||
| Operating Profit | |||||||||||||
| Depreciation | 0 | 0 | 0 | 375 | 375 | 375 | 300 | 375 | 375 | 375 | |||
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| Tax | |||||||||||||
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | 16,139 | 8,837 | -34,490 | 6,903 | -4,471 | 25,485 | 228,847 | -558 | -75,500 | 59,067 | -19,285 | -71,749 | 301,458 |
| Creditors | -1,000 | 6,107 | -35,160 | -3,900 | 6,900 | -55,385 | 2,343 | -21,298 | 188,690 | -211,212 | -108,349 | 219,828 | 160,953 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | |||||||||||||
| Investing Activities | |||||||||||||
| capital expenditure | |||||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | |||||||||||||
| Financing Activities | |||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -292,432 | 80,000 | 0 | 212,432 |
| share issue | |||||||||||||
| interest | |||||||||||||
| cash flow from financing | |||||||||||||
| cash and cash equivalents | |||||||||||||
| cash | 0 | 0 | 0 | 0 | 0 | -70,911 | -275,058 | -11,696 | 274,926 | -558,309 | -7,589 | 284,181 | 364,456 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 0 | 0 | 0 | 0 | 0 | -70,911 | -275,058 | -11,696 | 274,926 | -558,309 | -7,589 | 284,181 | 364,456 |
P&L
April 2022turnover
1.1m
0%
operating profit
17.1k
0%
gross margin
28%
-0.46%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
April 2022net assets
478k
+0.03%
total assets
626.5k
+0.02%
cash
0
0%
net assets
Total assets minus all liabilities
Similar Companies
silpharm limited company details
company number
01679089
Type
Private limited with Share Capital
industry
68209 - Letting and operating of own or leased real estate (other than Housing Association real estate and conference and exhibition services) n.e.c.
incorporation date
November 1982
age
42
accounts
Micro-Entity Accounts
ultimate parent company
previous names
N/A
incorporated
UK
address
11-12 hallmark trading centre, fourth way, wembley, middlesex, HA9 0LB
last accounts submitted
April 2022
silpharm limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 7 charges/mortgages relating to silpharm limited. Currently there are 3 open charges and 4 have been satisfied in the past.
silpharm limited Companies House Filings - See Documents
| date | description | view/download |
|---|
